{"originalText": "，患者因“胃癌”于2015-5-19于我院行“胃癌根治术”，术后恢复良好，，术后病理示：胃窦腺癌，中度分化，浸润溃疡型，体积8*5*2.2CM，侵穿浆膜，部分脉管内查见癌栓，并大弯侧、小弯侧脂肪组织内及大网膜内多灶性癌转移，双端切线未查见癌。呈四组（3/9个）、六组（1/6个）淋巴结癌转移及“肝圆韧带”癌转移。三组（2个）、五组（1个）、“1、3、7组”（13个）淋巴结未查见癌。，癌组织免疫组化染色示：β-TUBULIN-III局灶（+）、TS（-）、RRM1局灶（+）、TOPOII少数（+）、CERBB-2（-）、SYN（-）。，依情予行术后2疗程化疗：奥沙利铂150MG D1+亚叶酸钙0.3G D2-6+替加氟1GD2-6,化疗过程顺利，无明显不适，现为进一步治疗至我科就诊，遂依情以“胃恶性肿瘤术后”收入院。发病来，患者目前患者精神好，食欲一般，夜间睡眠可，小便正常，大便未诉异常，近期体重无明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 7}, {"end_pos": 28, "label_type": "手术", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 44, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 88, "end_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 92, "end_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 122, "end_pos": 142}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 186}, {"end_pos": 285, "label_type": "药物", "overlap": 0, "start_pos": 281}, {"end_pos": 298, "label_type": "药物", "overlap": 0, "start_pos": 294}, {"end_pos": 311, "label_type": "药物", "overlap": 0, "start_pos": 308}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 349, "end_pos": 356}]}
